|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/50 | (2017.02) |
| A61K 47/60 | (2017.02) | ||
| A61K 38/20 | (2006.01) | ||
| A61K 45/00 | (2006.01) | ||
| C07K 1/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2637694 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11840401.1 |
| Date of filing the European patent application | 2011-11-11 | |
| (97) | Date of publication of the European application | 2013-09-18 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-07 |
| (46) | Date of publication of the claims translation | 2021-05-25 |
| (86) | Number | PCT/US2011/060408 |
| Date | 2011-11-11 |
| (87) | Number | WO 2012/065086 |
| Date | 2012-05-18 |
| (30) | Number | Date | Country code |
| 413236 P | 2010-11-12 | US |
| (72) |
BOSSARD, Mary J., US
ALI, Cherie F., US
LIU, Xiaofeng, US
CHARYCH, Deborah H., US
WANG, Yujun, US
|
| (73) |
Nektar Therapeutics,
455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94158,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | IL-2 fragmento konjugtai ir polimeras |
| CONJUGATES OF AN IL-2 MOIETY AND A POLYMER |
| Payment date | Validity (years) | Amount | |
| 2025-10-14 | 15 | 289.00 EUR |
| 2026-11-11 |